FIA
WST icon

Foundations Investment Advisors’s West Pharmaceutical WST Stock Holding History

Foundations Investment Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.74M Sell
4,837
-911
-16% -$279K 0.02% 439
2026
Q1 		$1.44M Sell
5,748
-12
-0.2% -$2.99K 0.02% 437
2025
Q4 		$1.58M Buy
5,760
+33
+0.6% +$9.03K 0.02% 401
2025
Q3 		$1.5M Buy
5,727
+696
+14% +$169K 0.02% 373
2025
Q2 		$1.1M Sell
5,031
-9
-0.2% -$1.92K 0.02% 413
2025
Q1 		$1.13M Buy
5,040
+34
+0.7% +$9.37K 0.02% 381
2024
Q4 		$1.64M Buy
5,006
+5
+0.1% +$1.57K 0.03% 321
2024
Q3 		$1.5M Buy
5,001
+5
+0.1% +$1.53K 0.03% 310
2024
Q2 		$1.65M Sell
4,996
-42
-0.8% -$14.8K 0.04% 260
2024
Q1 		$1.99M Buy
+5,038
New +$1.86M 0.05% 231

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Foundations Investment Advisors's WST Position: Q2 2026 in Review

Foundations Investment Advisors reduced its West Pharmaceutical (WST) stake by 16% in Q2 2026, selling an estimated $279K and leaving 4,837 shares worth $1.74M. The position accounts for 0.02% of the portfolio, ranked #439.

Foundations Investment Advisors first reported a position in WST in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.99M in Q1 2024. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Foundations Investment Advisors held 4,837 shares of West Pharmaceutical worth $1.74M as of Q2 2026.
  • Foundations Investment Advisors sold 911 West Pharmaceutical shares in Q2 2026, an estimated $279K.
  • West Pharmaceutical made up 0.02% of Foundations Investment Advisors's portfolio in Q2 2026, its #439 holding.
  • Foundations Investment Advisors first reported a position in West Pharmaceutical in Q1 2024 and has held it in 10 quarters since.
  • Foundations Investment Advisors's West Pharmaceutical position peaked at $1.99M in Q1 2024.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Foundations Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.